You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High risk hematologic malignancy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical, Laboratory and Epidemiologic Characterization of

Recruiting
  • Waldenstrom Macroglobulinemia
  • +4 more
    • Bethesda, Maryland
    • +1 more
    Jan 25, 2023

    High Risk Hematologic Malignancy, Cord Blood Transplant Trial in Montréal (Transplant with an expanded ECT-001 cord blood)

    Recruiting
    • High Risk Hematologic Malignancy
    • Cord Blood Transplant
    • Transplant with an expanded ECT-001 cord blood
    • Montréal, Quebec, Canada
      CIUSSS de l'Est-de-l'île-de Montreal, Hôpital Maisonneuve-Rosemo
    Aug 2, 2021

    High Risk Hematological Malignancy, Cord Blood Transplant Trial in Seattle (ECT-001-CB (UM171-Expanded Cord Blood Transplant))

    Recruiting
    • High Risk Hematological Malignancy
    • Cord Blood Transplant
    • ECT-001-CB (UM171-Expanded Cord Blood Transplant)
    • Seattle, Washington
      Fred Hutchinson / University of Washington Cancer Consortium
    Jan 12, 2022

    Cancer Risk, Cancer Predisposition Syndrome, Hereditary Cancer Prediction Trial in Boston (Samples)

    Not yet recruiting
    • Cancer Risk
    • +30 more
    • Samples
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jul 14, 2022

    Hematologic Malignancy, Acute Myeloid Leukemia, MDS Trial in Chengdu, Shenzhen (CLL1-CD33 cCAR T cells)

    Recruiting
    • Hematologic Malignancy
    • +4 more
    • CLL1-CD33 cCAR T cells
    • Chengdu, China
    • +1 more
    May 17, 2021

    Hematologic Tumors Trial run by the NCI (donor lymphocyte infusion, Cyclophosphamide, Busulfan)

    Suspended
    • Hematologic Neoplasms
    • donor lymphocyte infusion
    • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Nov 30, 2022

    Hematologic Malignancy Trial in Saint Petersburg (Prophylactic Donor lymphocytes infusions, Preventive Donor lymphocytes

    Recruiting
    • Hematologic Malignancy
    • Prophylactic Donor lymphocytes infusions
    • Preventive Donor lymphocytes infusions
    • Saint Petersburg, Russian Federation
      RM Gorbacheva Research Institute
    Aug 16, 2021

    Hematologic Malignancy Trial in Durham (Exercise training)

    Recruiting
    • Hematologic Malignancy
    • Exercise training
    • Durham, North Carolina
      Duke Adult Blood and Marrow Transplant Clinic
    Dec 16, 2022

    Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)

    Not yet recruiting
    • Myeloid Malignancy
    • Acute Myeloid Leukemia
    • Cleveland, Ohio
      University Hospitals Seidman Cancer, Case Comprehensive Cancer C
    Nov 8, 2023

    Acute Myeloid Leukemia, B-cell Acute Lymphoblastic Leukemia, High-risk Myelodysplastic Syndrome Trial (VIP943)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • (no location specified)
    Sep 5, 2023

    Hypomethylating Agent, Venetoclax, Myeloid Malignancy Trial in Shanghai (Venetoclax, Azacitidine or decitabine)

    Recruiting
    • Hypomethylating Agent
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Jiao Tong University School of Medicine Affilated Shang
    May 2, 2023

    Multiple Myeloma, Cancer, Hematologic Cancer Trial in Cork (Discontinuation of maintenance treatment)

    Not yet recruiting
    • Multiple Myeloma
    • +2 more
    • Discontinuation of maintenance treatment
    • Cork, Ireland
      Cork University Hospital
    May 10, 2023

    MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)

    Recruiting
    • Myelodysplastic Syndromes, de Novo
    • +10 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 23, 2023

    Hematologic Disorders Trial in Aurora (Miltenyi CliniMACS® CD34 Reagent System)

    Recruiting
    • Hematologic Disorders
    • Miltenyi CliniMACS® CD34 Reagent System
    • Aurora, Colorado
      University of Colorado
    Feb 22, 2022

    Hematopoietic Stem Cell Transplantation, Malignant Hematological Diseases Trial in Suzhou (Umbilical Cord Blood Transplantation)

    Recruiting
    • Hematopoietic Stem Cell Transplantation
    • Malignant Hematological Diseases
    • Umbilical Cord Blood Transplantation
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow university
    Jul 3, 2023

    Metastatic Malignancy Trial in Houston (Atezolizumab, Tiragolumab)

    Not yet recruiting
    • Metastatic Malignancy
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 19, 2022

    Irradiated Bone Marrow, Transplant-Related Hematologic Malignancy, Leukemia, Acute Trial in Milano (Conditioning treatment

    Terminated
    • Irradiated Bone Marrow
    • +4 more
    • Conditioning treatment "Treosulfan-TMI"
    • +2 more
    • Milano, Lombardia, Italy
      Ospedale San Raffaele
    Oct 13, 2020

    Relapsed and/or Refractory Acute Myeloid Leukemia, High Risk Hematologic Malignancies Trial in Langfang (anti-CD33 CAR T cells)

    Not yet recruiting
    • Relapsed and/or Refractory Acute Myeloid Leukemia
    • High Risk Hematologic Malignancies
    • anti-CD33 CAR T cells
    • Langfang, Hebei, China
      Hebei Yanda Lu Daopei Hospital
    Jun 30, 2022

    Relapsed/Refractory, High Risk Hematologic Malignancies, T-ALL/Lymphoma Trial in Langfang (CD7CAR T cells)

    Recruiting
    • Relapsed/Refractory, High Risk Hematologic Malignancies
    • T-ALL/Lymphoma
    • CD7CAR T cells
    • Langfang, Hebei, China
      Hebei Yanda Lu Daopei Hospital
    Jun 30, 2022

    Leukemia, Myeloid, Acute, MDS, Hematopoietic Stem Cell Transplantation Trial in Shanghai (Venetoclax plus RIC)

    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • +3 more
    • Venetoclax plus RIC
    • Shanghai, Shanghai, China
      Shanghai General Hospital
    Oct 12, 2022

    Sickle Cell Disease, Thalassemia, High Risk Hematologic Disorders Trial in Minneapolis (Blood and Marrow Transplant)

    Recruiting
    • Sickle Cell Disease
    • +4 more
    • Blood and Marrow Transplant
    • Minneapolis, Minnesota
      Masonic Caner Center at University of Minnesota
    May 23, 2022

    Avera/Sema4 Oncology and Analytics Protocol

    Recruiting
    • Cancer
    • +11 more
      • Sioux Falls, South Dakota
        Avera Cancer Institute
      Jan 30, 2023

      Hematologic Malignancies, Relapse, GVHD Trial in Ann Arbor (Carfilzomib, Tacrolimus)

      Completed
      Has Results
      • Hematologic Malignancies
      • +2 more
      • Ann Arbor, Michigan
        University of Michigan Hospital
      Dec 3, 2021

      Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete

      Completed
      Has Results
      • Myeloproliferative Disorders
      • +4 more
      • T-cell replete PBPC allograft
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Oct 12, 2022

      Chemotherapy for Gynecological Malignancy in High-risk Region of

      Active, not recruiting
      • Gynecological Cancer
      • Wuhan, Hubei, China
        Tongji Hospital, Tongji Medical College, Huazhong University of
      Oct 6, 2021